Live feed08:10:17·26mANALYSTRatingvia QuantisnowBioMarin Pharmaceutical upgraded by Raymond James with a new price targetByQuantisnow·Wall Street's wire, on your screen.BMRN· BioMarin Pharmaceutical Inc.Health CareOriginal source